Aeglea BioTherapeutics, Inc. (AGLE) financial statements (2022 and earlier)

Company profile

Business Address 805 LAS CIMAS PARKWAY
AUSTIN, TX 78746
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:93,128146,27371,94974,50050,30063,500
Cash and cash equivalents15,14290,09519,25322,46112,81747,748
Short-term investments77,98656,17852,69652,05237,48215,754
Other undisclosed cash, cash equivalents, and short-term investments   (13)1(2)
Receivables815   3,0781,215
Other undisclosed current assets4,9483,5162,5562,1711,6131,709
Total current assets:98,891149,78974,50576,67154,99166,424
Noncurrent Assets
Operating lease, right-of-use asset3,8064,2304,726
Property, plant and equipment4,5495,6422,3851,018854599
Restricted cash and investments1,8381,8421,500   
Other noncurrent assets842115675023240
Total noncurrent assets:11,03511,8298,6781,0681,086639
TOTAL ASSETS:109,926161,61883,18377,73956,07767,063
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,3547,5047,5234,2463,0572,145
Accounts payable3,3192,2543,154663389168
Accrued liabilities3,0471,5381,096940831707
Employee-related liabilities4,9883,7123,2732,6431,8371,270
Deferred revenue2,359  
Debt41827379   
Deferred revenue and credits2071
Other undisclosed current liabilities6,0138,91210,4575,9932,5521,749
Total current liabilities:20,14416,44318,35910,2395,6293,965
Noncurrent Liabilities
Long-term debt and lease obligation4,6085,1294,712   
Operating lease, liability4,6085,1294,712
Liabilities, other than long-term debt1,2332143172111132
Deferred revenue1,217  
Other liabilities162143172111132
Total noncurrent liabilities:5,8415,3434,74372111132
Total liabilities:25,98521,78623,10210,3115,7404,097
Stockholders' equity
Stockholders' equity attributable to parent83,941139,83260,08167,42850,33762,966
Common stock553221
Additional paid in capital425,765415,824255,142184,314122,950108,246
Accumulated other comprehensive income (loss)(20)1151(27)(102)(4)
Accumulated deficit(341,809)(276,008)(195,115)(116,861)(72,513)(45,277)
Total stockholders' equity:83,941139,83260,08167,42850,33762,966
TOTAL LIABILITIES AND EQUITY:109,926161,61883,18377,73956,07767,063

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues18,739  3,8885,2054,628
Revenue, net5,2054,628
Gross profit:18,739  3,8885,2054,628
Operating expenses(84,388)(81,481)(80,334)(49,351)(32,881)(26,534)
Operating loss:(65,649)(81,481)(80,334)(45,463)(27,676)(21,906)
Nonoperating income (expense)(11)5882,0801,115440208
Investment income, nonoperating1115932,1431,172482244
Other nonoperating expense(122)(5)(63)(57)(42)(36)
Loss from continuing operations before income taxes:(65,660)(80,893)(78,254)(44,348)(27,236)(21,698)
Income tax expense(141)     
Net loss available to common stockholders, diluted:(65,801)(80,893)(78,254)(44,348)(27,236)(21,698)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(65,801)(80,893)(78,254)(44,348)(27,236)(21,698)
Comprehensive loss:(65,801)(80,893)(78,254)(44,348)(27,236)(21,698)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(31)(40)7875(98)(3)
Comprehensive loss, net of tax, attributable to parent:(65,832)(80,933)(78,176)(44,273)(27,334)(21,701)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: